These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10548901)

  • 1. [Pharma-clinics. Drug of the month. Zaleplon (Sonata)].
    Ansseau M
    Rev Med Liege; 1999 Aug; 54(8):705-6. PubMed ID: 10548901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zaleplon for insomnia.
    Med Lett Drugs Ther; 1999 Oct; 41(1063):93-4. PubMed ID: 10535052
    [No Abstract]   [Full Text] [Related]  

  • 3. Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
    Weitzel KW; Wickman JM; Augustin SG; Strom JG
    Clin Ther; 2000 Nov; 22(11):1254-67. PubMed ID: 11117652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of zaleplon at peak plasma levels.
    Mangano RM
    Int J Clin Pract Suppl; 2001 Jan; (116):9-13. PubMed ID: 11219331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.
    Heydorn WE
    Expert Opin Investig Drugs; 2000 Apr; 9(4):841-58. PubMed ID: 11060714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zaleplon: a review of its use in the treatment of insomnia.
    Dooley M; Plosker GL
    Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of zaleplon in the treatment of insomnia.
    Israel AG; Kramer JA
    Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.
    Fry J; Scharf M; Mangano R; Fujimori M
    Int Clin Psychopharmacol; 2000 May; 15(3):141-52. PubMed ID: 10870872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group.
    Hedner J; Yaeche R; Emilien G; Farr I; Salinas E
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):704-12. PubMed ID: 10960882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NICE review: not nice for patients!
    Alford C; Verster J
    J Psychopharmacol; 2005 Mar; 19(2):129-32. PubMed ID: 15728431
    [No Abstract]   [Full Text] [Related]  

  • 12. NICE: The National Institute of Clinical Excellence -- or Eccentricity? Reflections on the Z-drugs as hypnotics.
    Nutt DJ
    J Psychopharmacol; 2005 Mar; 19(2):125-7. PubMed ID: 15728430
    [No Abstract]   [Full Text] [Related]  

  • 13. Consequences of insomnia and its therapies.
    Benca RM
    J Clin Psychiatry; 2001; 62 Suppl 10():33-8. PubMed ID: 11388589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term use of sedative hypnotics in older patients with insomnia.
    Ancoli-Israel S; Richardson GS; Mangano RM; Jenkins L; Hall P; Jones WS
    Sleep Med; 2005 Mar; 6(2):107-13. PubMed ID: 15716214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazolopyrimidines.
    George CF
    Lancet; 2001 Nov; 358(9293):1623-6. PubMed ID: 11716908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptual disturbances with zaleplon.
    Bhatia SC; Arora M; Bhatia SK
    Psychiatr Serv; 2001 Jan; 52(1):109-10. PubMed ID: 11141544
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of L-846 in patients with insomnia: evaluation by polysomnography.
    Sakamoto T; Uchimura N; Mukai M; Mizuma H; Shirakawa SI; Nakazawa Y
    Psychiatry Clin Neurosci; 1998 Apr; 52(2):156-7. PubMed ID: 9628124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
    Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
    Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of insomnia with zaleplon, a novel sleep medication.
    Doghramji PP
    Int J Clin Pract; 2001 Jun; 55(5):329-34. PubMed ID: 11452683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats.
    Noguchi H; Kitazumi K; Mori M; Shiba T
    J Pharmacol Sci; 2004 Mar; 94(3):246-51. PubMed ID: 15037809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.